Home Newsfeeds Truist Securities Maintains Buy on Wingstop, Lowers Price Target to $130

Truist Securities Maintains Buy on Wingstop, Lowers Price Target to $130

Truist Securities analyst Jake Bartlett maintains Wingstop (NASDAQ:WING) with a Buy and lowers the price target from $160 to $130.

byBenzinga Newsdesk

July 1, 2022

1 minute read

Truist Securities analyst Jake Bartlett maintains Wingstop (NASDAQ:WING) with a Buy and lowers the price target from $160 to $130.

Alibaba Is Top Pick, Analyst Boosts Estimates Expecting Growth Recovery And Easing Logistics From Fiscal 24

By Anusuya Lahiri

January 10, 4:22 PM

Benchmark analyst Fawne Jiang reiterated Buy on Alibaba Group Holding Limited (NYSE: BABA)

BABA

Markets Bet On U.S. Stock Futures With Easing Fear Levels

By Lisa Levin

August 3, 5:34 AM

The overall fear level saw some easing in the US equity markets, despite the Wall Street settling lower on Tuesday, according to the CNN Money Fear and Greed index. Wall street closed a choppy session on a lower note on Tuesday amid rising tensions between the U.S. and China.

CAT

IMUNON Announces First Patient Enrolled In Phase 1/2 Clinical Trial Of IMNN-001 In Combination With bevacizumab In Advanced Ovarian Cancer

By Benzinga Newsdesk

October 18, 8:32 AM

The MRD trial will evaluate the effect of this treatment combination on minimal residual disease.LAWRENCEVILLE, N.J., Oct. 18, 2023 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ:IMNN), a clinical-stage drug-development

IMNN

Bill Ackman Turns Heat On PepsiCo, Coca-Cola But Warren Buffett Fan Points Finger Back: What About Pershing’s Own Top 4 Holdings?

By Shanthi Rexaline

January 3, 3:07 AM

Pershing Square’s Bill Ackman took to Twitter on Monday to slam PepsiCo (NYSE: PEP) a

BRKA

Truist Securities Maintains Buy on Wingstop, Lowers Price Target to $130

Related Posts

Alibaba Is Top Pick, Analyst Boosts Estimates Expecting Growth Recovery And Easing Logistics From Fiscal 24

Markets Bet On U.S. Stock Futures With Easing Fear Levels

IMUNON Announces First Patient Enrolled In Phase 1/2 Clinical Trial Of IMNN-001 In Combination With bevacizumab In Advanced Ovarian Cancer

Bill Ackman Turns Heat On PepsiCo, Coca-Cola But Warren Buffett Fan Points Finger Back: What About Pershing’s Own Top 4 Holdings?